Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Long‐term safety and efficacy of deferasirox (Exjade<sup>®</sup>) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease
PaperCitations, authors & open-access status
Long‐term safety and efficacy of deferasirox (Exjade<sup>®</sup>) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 78 citations, 2011 year and green oa status.
78
Citations
2011
Year
green
OA Status